Ximenes V F, Catalani L H, Campa A
Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, CEP 05508-900, São Paulo, Brazil.
Biochem Biophys Res Commun. 2001 Sep 14;287(1):130-4. doi: 10.1006/bbrc.2001.5557.
We recently described that horseradish peroxidase (HRP) and myeloperoxidase (MPO) catalyze the oxidation of melatonin, forming the respective indole ring-opening product N(1)-acetyl-N(2)-formyl-5-methoxykynuramine (AFMK) (Biochem. Biophys. Res. Commun. 279, 657-662, 2001). Although the classic peroxidatic enzyme cycle is expected to participate in the oxidation of melatonin, the requirement of a low HRP:H(2)O(2) ratio suggested that other enzyme paths might also be operative. Here we followed the formation of AFMK under two experimental conditions: predominance of HRP compounds I and II or presence of compound III. Although the consumption of substrate is comparable under both conditions, AFMK is formed in significant amounts only when compound III predominates during the reaction. Using tryptophan as substrate, N- formyl-kynurenine is formed in the presence of compound III. Both, melatonin and tryptophan efficiently prevents the formation of p-670, the inactive form of HRP. Since superoxide dismutase (SOD) inhibits the production of AFMK, we proposed that compound III acts as a source of O(-*)(2) or participates directly in the reaction, as in the case of enzyme indoleamine 2,3-dioxygenase.
我们最近报道,辣根过氧化物酶(HRP)和髓过氧化物酶(MPO)催化褪黑素的氧化,形成各自的吲哚环开裂产物N(1)-乙酰基-N(2)-甲酰基-5-甲氧基犬尿胺(AFMK)(《生物化学与生物物理研究通讯》279,657 - 662,2001)。虽然经典的过氧化物酶循环预期参与褪黑素的氧化,但低HRP:H₂O₂比值的要求表明其他酶途径可能也起作用。在此,我们在两种实验条件下追踪AFMK的形成:HRP化合物I和II占优势或化合物III存在。虽然在两种条件下底物的消耗相当,但仅当化合物III在反应过程中占优势时,才会大量形成AFMK。以色氨酸为底物时,在化合物III存在的情况下会形成N-甲酰基犬尿氨酸。褪黑素和色氨酸都能有效阻止HRP的无活性形式p-670的形成。由于超氧化物歧化酶(SOD)抑制AFMK的产生,我们提出化合物III作为O₂⁻的来源或直接参与反应,如同吲哚胺2,3-双加氧酶的情况。